Spain launches Aspen Pharma probe

Spain’s National Authority for Markets and Competition last week began an investigation of South African drugmaker Aspen Pharma and its Spanish distributor for allegedly restricting the supply and fixing the price of several pharmaceuticals.

Get unlimited access to all Global Competition Review content